Biogen and Human Immunology Biosciences (HI-Bio), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune...
Biogen and Reata Pharmaceuticals announced late last week that Biogen has agreed to acquire Reata for €156.51 per share in cash, reflecting an enterprise value of...
US biotech Sangamo Therapeutics is studying alternative options to advance its neurological disease programs after both Novartis and Biogen ended their respective...
The US Court of Appeals for the Federal Circuit on Sept. 28 set aside a decision of the US district court of New Jersey in Newark, reversing the district court’s earlier...
13.03.2020
- Biogen and Vir Biotechnology, the new company of its former Biogen CEO George Scangos, have signed a letter of intent to develop and manufacture a new antibody to fight COVID-19...
06.12.2019
- The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...
13.03.2019
- Japan’s Fujifilm is boosting its healthcare business with the proposed acquisition of Biogen (Denmark) Manufacturing for around $890 million in cash. The deal gives Fujifilm a...
08.03.2019
- Biogen has agreed to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, UK. The US drug firm will pay Nightstar shareholders $25.50 for each...
